Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes

References

• AK Futures LLC v. Boyd Street Distro LLC. 2022. No. 21-56133 United State Court of Appeals for the Ninth Circuit. May 19. https://cdn.ca9.uscourts.gov/datastore/opinions/2022/05/19/21-56133.pdf.
   Google Scholar
• Anthony, J. C., C. Lopez-Quintero, and O. Alshaarawy. 2017. Cannabis epidemiology: A selective review. Current Pharmaceutical Design 22 (42):6340–52. doi:10.2174/1381612822666160813214023.
   PubMed Web of Science ®Google Scholar
• Babalonis, S., W. M. Raup-Konsavage, P. D. Akpunonu, A. Balla, and K. E. Vrana. 2021. D8-THC: Legal status, widespread availability, and safety concerns. Cannabis and Cannabinoid Research 6 (5):362–65. doi:10.1089/can.2021.0097.
   PubMedGoogle Scholar
• Bastien, C. 2001. Validation of the Insomnia severity index as an outcome measure for insomnia research. Sleep Medicine 2 (4):297–307. doi:10.1016/S1389-9457(00)00065-4.
   PubMed Web of Science ®Google Scholar
• Bergeria, C. L., J. C. Strickland, T. R. Spindle, M. Kalaba, P. U. Satyavolu, M. Feldner, R. Vandrey, M. Bonn-Miller, E. N. Peters, and E. Weerts. 2022. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol. Experimental and Clinical Psychopharmacology 31 (2):312–17. doi:10.1037/pha0000565.
   PubMed Web of Science ®Google Scholar
• Camí, J., D. Guerra, B. Ugena, J. Segura, and R. De La Torre. 1991. Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes. Pharmacology, Biochemistry, and Behavior 40 (1):115–19. doi:10.1016/0091-3057(91)90330-5.
   PubMed Web of Science ®Google Scholar
• Carliner, H., Q. L. Brown, A. L. Sarvet, and D. S. Hasin. 2017. Cannabis use, attitudes, and legal status in the U.S.: A review. Preventive Medicine 104:13–23. doi:10.1016/j.ypmed.2017.07.008.
   PubMed Web of Science ®Google Scholar
• Chiu, V., W. Hall, G. Chan, L. Hides, and J. Leung. 2022. A systematic review of trends in US attitudes toward cannabis legalization. Substance Use & Misuse 57 (7):1052–61. doi:10.1080/10826084.2022.2063893.
   PubMed Web of Science ®Google Scholar
• Colder, C. R., Y. H. Lee, S. Frndak, J. P. Read, and W. F. Wieczorek. 2019. Internalizing symptoms and cannabis and alcohol use: Between- and within-person risk pathways with coping motives. Journal of Consulting and Clinical Psychology 87 (7):629–44. doi:10.1037/ccp0000413.
   PubMed Web of Science ®Google Scholar
• Crippa, J. A., A. W. Zuardi, R. Martín-Santos, S. Bhattacharyya, Z. Atakan, P. McGuire, and P. Fusar-Poli. 2009. Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology: Clinical and Experimental 24 (7):515–23. doi:10.1002/hup.1048.
   PubMed Web of Science ®Google Scholar
• Cuttler, C., and A. Spradlin. 2017. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU). Plos One 12 (5):e0178194. doi:10.1371/journal.pone.0178194.
   PubMed Web of Science ®Google Scholar
• Danielsson, A.-K., A. Lundin, E. Agardh, P. Allebeck, and Y. Forsell. 2016. Cannabis use, depression and anxiety: A 3-year prospective population-based study. Journal of Affective Disorders 193:103–08. doi:10.1016/j.jad.2015.12.045.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., W. Hall, M. Lynskey, C. Coffey, and G. Patton. 2011. The association between cannabis use and depression: A review of the evidence. In Marijuana and Madness, ed. D. Castle, R. M. Murray, and D. C. DSouza, 2nd ed., 114–28. Cambridge University Press. doi:10.1017/CBO9780511706080.011.
   Google Scholar
• Dotson, S., K. Johnson‐arbor, R. M. Schuster, B. Tervo‐clemmens, and A. E. Evins. 2022. Unknown risks of psychosis and addiction with delta‐8‐THC: A call for research, regulation, and clinical caution. Addiction 117 (9):2371–73. add.15873. doi:10.1111/add.15873.
   PubMed Web of Science ®Google Scholar
• Faul, F., E. Erdfelder, A. Buchner, and A. -G. Lang. 2009. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods 41 (4):1149–60. doi:10.3758/BRM.41.4.1149.
   PubMed Web of Science ®Google Scholar
• Felson, J., A. Adamczyk, and C. Thomas. 2019. How and why have attitudes about cannabis legalization changed so much? Social Science Research 78:12–27. doi:10.1016/j.ssresearch.2018.12.011.
   PubMed Web of Science ®Google Scholar
• Glodosky, N. C., and C. Cuttler. 2020. Motives matter: Cannabis use motives moderate the associations between stress and negative affect. Addictive Behaviors 102:106188. doi:10.1016/j.addbeh.2019.106188.
   PubMed Web of Science ®Google Scholar
• Harrison, L. D. 1995. The validity of self-reported data on drug use. Journal of Drug Issues 25 (1):91–111. doi:10.1177/002204269502500107.
   Web of Science ®Google Scholar
• Hollister, L. E., and H. K. Gillespie. 1973. Delta-8- and delta-9-tetrahydrocannabinol; Comparison in man by oral and intravenous administration. Clinical Pharmacology & Therapeutics 14 (3):353–57. doi:10.1002/cpt1973143353.
   PubMed Web of Science ®Google Scholar
• Jamnik, M. R., and D. J. Lane. 2017. The use of Reddit as an inexpensive source for high-quality data. Practical Assessment, Research, and Evaluation 22 (5):1–10. doi:10.7275/J18T-C009.
   Google Scholar
• Kaur, N., K. M. Keyes, A. D. Hamilton, C. Chapman, M. Livingston, T. Slade, and W. Swift. 2021. Trends in cannabis use and attitudes toward legalization and use among Australians from 2001–2016: An age‐period‐cohort analysis. Addiction 116 (5):1152–61. doi:10.1111/add.15271.
   PubMed Web of Science ®Google Scholar
• Kirk, J., P. Doty, and H. De Wit. 1998. Effects of expectancies on subjective responses to oral Δ9-tetrahydrocannabinol. Pharmacology, Biochemistry, and Behavior 59 (2):287–93. doi:10.1016/S0091-3057(97)00414-0.
   PubMed Web of Science ®Google Scholar
• Kruger, D. J., and J. S. Kruger. 2021. Consumer experiences with delta-8-THC: Medical use, pharmaceutical substitution, and comparisons with delta-9-THC. Cannabis and Cannabinoid Research 8 (1):166–73. can.2021.0124. doi:10.1089/can.2021.0124.
   PubMedGoogle Scholar
• Kruger, J. S., and D. J. Kruger. 2022. Delta-8-THC: Delta-9-THC’s nicer younger sibling? Journal of Cannabis Research 4 (1):4. doi:10.1186/s42238-021-00115-8.
   PubMedGoogle Scholar
• Leas, E. C. 2021. The hemp loophole: A need to clarify the legality of delta-8-THC and other hemp-derived tetrahydrocannabinol compounds. American Journal of Public Health 111 (11):1927–31. doi:10.2105/AJPH.2021.306499.
   PubMed Web of Science ®Google Scholar
• Leas, E. C., A. L. Nobles, Y. Shi, and E. Hendrickson. 2022. Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use. International Journal of Drug Policy 101:103557. doi:10.1016/j.drugpo.2021.103557.
   PubMed Web of Science ®Google Scholar
• Leibowitz, M. R. 1987. Social phobia. Modern Problems in Pharmacopsychiatry 22:141–73.
   PubMedGoogle Scholar
• Livingston, M. D., A. Walker, M. B. Cannell, and M. E. Rossheim. 2022. Popularity of Delta-8 THC on the Internet across US states, 2021. American Journal of Public Health 112 (2):296–99. doi:10.2105/AJPH.2021.306586.
   PubMed Web of Science ®Google Scholar
• Livne, O., A. Budney, J. Borodovsky, C. Walsh, D. Shmulewitz, D. S. Fink, C. A. Struble, M. Habib, E. Aharonovich, and D. S. Hasin. 2022. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates. Addictive Behaviors 133:107374. doi:10.1016/j.addbeh.2022.107374.
   PubMed Web of Science ®Google Scholar
• Metrik, J., C. W. Kahler, J. E. McGeary, P. M. Monti, and D. J. Rohsenow. 2011. Acute effects of marijuana smoking on negative and positive affect. Journal of Cognitive Psychotherapy 25 (1):31–46. doi:10.1891/0889-8391.25.1.31.
   Google Scholar
• Morin, C. M., G. Belleville, L. Bélanger, and H. Ivers. 2011. The Insomnia severity index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34 (5):601–08. doi:10.1093/sleep/34.5.601.
   PubMed Web of Science ®Google Scholar
• Park, J. -Y., and L. -T. Wu. 2017. Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug and Alcohol Dependence 177:1–13. doi:10.1016/j.drugalcdep.2017.03.009.
   PubMed Web of Science ®Google Scholar
• Patton, D. V. 2020. A history of United States cannabis law. Journal of Law & Health 34 (1):1–29.
   PubMedGoogle Scholar
• Petti, T. A., and J. C. Chatlos. 2021. Implications of cannabis legalization: A national and international perspective. Adolescent Psychiatry 11 (2):80–94. doi:10.2174/2210676611666210823093245.
   Web of Science ®Google Scholar
• Plummer, F., L. Manea, D. Trepel, and D. McMillan. 2016. Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. General Hospital Psychiatry 39:24–31. doi:10.1016/j.genhosppsych.2015.11.005.
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. 1977. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1 (3):385–401. doi:10.1177/014662167700100306.
   Web of Science ®Google Scholar
• R Core Team. 2022. R: A language and environment for statistical computing (3.5.1).
   Google Scholar
• Rueger, S. Y., C. J. Trela, M. Palmeri, and A. C. King. 2012. Self-administered web-based timeline followback procedure for drinking and smoking behaviors in young adults. Journal of Studies on Alcohol and Drugs 73 (5):829–33. doi:10.15288/jsad.2012.73.829.
   PubMed Web of Science ®Google Scholar
• Rytwinski, N. K., D. M. Fresco, R. G. Heimberg, M. E. Coles, M. R. Liebowitz, S. Cissell, M. B. Stein, and S. G. Hofmann. 2009. Screening for social anxiety disorder with the self-report version of the Liebowitz social anxiety scale. Depression and Anxiety 26 (1):34–38. doi:10.1002/da.20503.
   PubMed Web of Science ®Google Scholar
• Salas-Wright, C. P., A. H. Hai, S. Oh, A. Alsolami, and M. G. Vaughn. 2021. Trends in cannabis views and use among American adults: Intersections with alcohol consumption, 2002–2018. Addictive Behaviors 116:106818. doi:10.1016/j.addbeh.2021.106818.
   PubMed Web of Science ®Google Scholar
• Schultz, N. R., D. T. Bassett, B. G. Messina, and C. J. Correia. 2019. Differential role of cannabis use motives in predicting impairment across three measures. Journal of Studies on Alcohol and Drugs 80 (1):26–31. doi:10.15288/jsad.2019.80.26.
   PubMed Web of Science ®Google Scholar
• Simons, J., C. J. Correia, K. B. Carey, and B. E. Borsari. 1998. Validating a five-factor marijuana motives measure: Relations with use, problems, and alcohol motives. Journal of Counseling Psychology 45 (3):265–73. doi:10.1037/0022-0167.45.3.265.
   Web of Science ®Google Scholar
• Sobell, L. C., and M. B. Sobell. 1992. Timeline follow-back. In Measuring Alcohol Consumption, ed. R. Z. Litten and J. P. Allen, 41–72. Humana Press. doi: 10.1007/978-1-4612-0357-5_3.
   Google Scholar
• Spitzer, R. L., K. Kroenke, J. B. W. Williams, and B. Löwe. 2006. A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine 166 (10):1092. doi:10.1001/archinte.166.10.1092.
   PubMed Web of Science ®Google Scholar
• Stephens, R. S., R. A. Roffman, and L. Curtin. 2000. Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology 68 (5):898–908. doi:10.1037/0022-006X.68.5.898.
   PubMed Web of Science ®Google Scholar
• Tagen, M., and L. E. Klumpers. 2022. Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC. British Journal of Pharmacology 179 (15):3915–33. doi:10.1111/bph.15865.
   PubMed Web of Science ®Google Scholar
• Vilagut, G., C. G. Forero, G. Barbaglia, and J. Alonso. 2016. Screening for depression in the general population with the Center for Epidemiologic Studies Depression (CES-D): A systematic review with meta-analysis. Plos One 11 (5):e0155431. doi:10.1371/journal.pone.0155431.
   PubMed Web of Science ®Google Scholar
• Wurz, G. T., E. Montoya, and M. W. DeGregorio. 2022. Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ8-tetrahydrocannabinol: Case studies. Journal of Cannabis Research 4 (1):36. doi:10.1186/s42238-022-00146-9.
   PubMedGoogle Scholar